Search research articles
Contact Us
Filters
Showing results (321-330 of 331) with videos related to
Page
of 34
Sort By:
Eclinicalmedicine
|
April 12, 2023
Nirmatrelvir/ritonavir in COVID-19 patients with haematological malignancies: a report from the EPICOVIDEHA registry
Jon Salmanton-García, Francesco Marchesi, Maria Gomes da Silva, et al.
Hematological Oncology
|
December 5, 2023
Survival in multiple myeloma and SARS-COV-2 infection through the COVID-19 pandemic: Results from the EPICOVIDEHA registry
Pellegrino Musto, Jon Salmanton-García, Nicola Sgherza, et al.
American Journal of Hematology
|
December 23, 2024
Respiratory Viruses in Patients With Hematological Malignancy in Boreal Autumn/Winter 2023-2024: EPICOVIDEHA-EPIFLUEHA Report
Jon Salmanton-García, Francesco Marchesi, Milan Navrátil, et al.
American Journal of Hematology
|
December 24, 2025
Beyond the Usual Suspects: RSV Infection in Patients With Hematological Malignancies Compared to Influenza and SARS-COV-2-A Report From the EPICOVIDEHA/EPIRESEHA Registry
Jon Salmanton-García, Francesco Marchesi, Milan Navrátil, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
October 20, 2023
Age, successive waves, immunization, and mortality in elderly COVID-19 hematological patients: EPICOVIDEHA findings
Giuseppe Rossi, Jon Salmanton-García, Chiara Cattaneo, et al.
Haematologica
|
April 4, 2024
Dexamethasone treatment for COVID-19 is related to increased mortality in hematologic malignancy patients: results from the EPICOVIDEHA registry
Tommaso Francesco Aiello, Jon Salmanton-Garcia, Francesco Marchesi, et al.
Infection
|
May 21, 2024
Correction: Need for ICU and outcome of critically ill patients with COVID-19 and haematological malignancies: results from the EPICOVIDEHA survey
Tobias Lahmer, Jon Salmanton-García, Francesco Marchesi, et al.
Infection
|
February 22, 2024
Need for ICU and outcome of critically ill patients with COVID-19 and haematological malignancies: results from the EPICOVIDEHA survey
Tobias Lahmer, Jon Salmanton-García, Francesco Marchesi, et al.
Nature Medicine
|
February 13, 2018
Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells
Nimitha R Mathew, Francis Baumgartner, Lukas Braun, et al.
Nature Medicine
|
April 11, 2018
Erratum: Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells
Nimitha R Mathew, Francis Baumgartner, Lukas Braun, et al.
Page
of 34
Search research articles
Search
Showing results (321-330 of 331) with videos related to
Sort By:
Page
of 34
Eclinicalmedicine
|
April 12, 2023
Nirmatrelvir/ritonavir in COVID-19 patients with haematological malignancies: a report from the EPICOVIDEHA registry
Jon Salmanton-García, Francesco Marchesi, Maria Gomes da Silva, et al.
Hematological Oncology
|
December 5, 2023
Survival in multiple myeloma and SARS-COV-2 infection through the COVID-19 pandemic: Results from the EPICOVIDEHA registry
Pellegrino Musto, Jon Salmanton-García, Nicola Sgherza, et al.
American Journal of Hematology
|
December 23, 2024
Respiratory Viruses in Patients With Hematological Malignancy in Boreal Autumn/Winter 2023-2024: EPICOVIDEHA-EPIFLUEHA Report
Jon Salmanton-García, Francesco Marchesi, Milan Navrátil, et al.
American Journal of Hematology
|
December 24, 2025
Beyond the Usual Suspects: RSV Infection in Patients With Hematological Malignancies Compared to Influenza and SARS-COV-2-A Report From the EPICOVIDEHA/EPIRESEHA Registry
Jon Salmanton-García, Francesco Marchesi, Milan Navrátil, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
October 20, 2023
Age, successive waves, immunization, and mortality in elderly COVID-19 hematological patients: EPICOVIDEHA findings
Giuseppe Rossi, Jon Salmanton-García, Chiara Cattaneo, et al.
Haematologica
|
April 4, 2024
Dexamethasone treatment for COVID-19 is related to increased mortality in hematologic malignancy patients: results from the EPICOVIDEHA registry
Tommaso Francesco Aiello, Jon Salmanton-Garcia, Francesco Marchesi, et al.
Infection
|
May 21, 2024
Correction: Need for ICU and outcome of critically ill patients with COVID-19 and haematological malignancies: results from the EPICOVIDEHA survey
Tobias Lahmer, Jon Salmanton-García, Francesco Marchesi, et al.
Infection
|
February 22, 2024
Need for ICU and outcome of critically ill patients with COVID-19 and haematological malignancies: results from the EPICOVIDEHA survey
Tobias Lahmer, Jon Salmanton-García, Francesco Marchesi, et al.
Nature Medicine
|
February 13, 2018
Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells
Nimitha R Mathew, Francis Baumgartner, Lukas Braun, et al.
Nature Medicine
|
April 11, 2018
Erratum: Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells
Nimitha R Mathew, Francis Baumgartner, Lukas Braun, et al.
Page
of 34